Company* (Country; Symbol)

Company* (Country; Symbol)

Product

Terms/Details (Date)

Amarillo Biosciences Inc. (OTC BB:AMAR)

Global Kinetics Inc.*

Global Kinetics will market ABI's low-dose oral interferon product in Cambodia, Laos and Vietnam

The product will be marketed for influenza indications; terms of the deal were not disclosed (10/20)

Biophage Pharma Inc. (Canada; TSE:BUG)

Integrated Environmental Technologies Ltd. (OTC BB:IEVM)

Deal under which each company can market a pathogen detection and control system

The combined marketing effort will promote IET's EcaFlo equipment and Biophage's PDS Biosensor technology (9/23)

Geneva Bioinformatics SA* (Switzerland)

Genedata AG* (Switzerland)

Deal under which they will integrate technologies for analyzing proteomics data

The effort will integrate the Genedata Expressionist solution with the Melanie/ ImageMaster 2D Platinum solution (10/26)

GTC Biotherapeutics Inc. (GTCB)

Merrimack Pharmaceuticals Inc.*

Deal for the further production of Merrimack's MM-093 by GTC

The product is a recombinant version of human alpha-fetoprotein in Phase II trials for rheumatoid arthritis; terms were not disclosed (9/20)

JPT Peptide Technologies GmbH* (Germany)

Quality Biological Inc.*

Nonexclusive deal under which QBI will distribute JPT's peptide-based products in America

JPT is a wholly owned subsidiary of Jerini AG; terms of the deal were not disclosed (9/15)

Nonlinear Dynamics Ltd.* (UK)

Genedata AG* (Switzerland)

Co-marketing deal to promote synergies between their Progenesis and Expressionist solutions

The solution will be used to generate data in proteomics research; terms of the deal were not disclosed (10/20)

Nonlinear Dynamics Ltd.* (UK)

Invitrogen Corp. (IVGN)

Invitrogen will promote and distribute life science analysis software from Nonlinear

The deal covers a number of products; terms were not disclosed (8/29)

Peregrine Pharmaceuticals Inc. (PPHM)

Undisclosed company

Peregrine will provide development services and clinical supply manufacturing of a monoclonal antibody

The antibody is in Phase II trials; the work will be done by Peregrine subsidiary Avid Bioservices Inc. (10/20)

Pluristem Life Systems Inc. (Israel; OTC BB:PLRS)

Biological Industries Ltd.*

Deal for the global distribution of project products in the field of serum-free media designed for hematopoietic and mesenchymal stem cells

Pluristem's Plurix cell expansion system will be used in the effort; Pluristem will get a license fee equal to five percent of sales of resulting media for seven years (10/20)

Progenitor Cell Therapy LLC*

Cellerant Therapeutics Inc.*

Progenitor will manufacture Cellerant's CLT-001

CLT-001 is a purified hematopoietic stem cell product being developed for various diseases; terms were not disclosed (9/13)

Solvo Biotechnologies Inc.* (Hungary)

In Vitro Technologies Inc.*

IVT will distribute Solvo's in vitro ABC membrane transporter assay product line in the U.S. and Canada

Terms of the deal were not disclosed (10/24)

Transgene SA (France; Eurolist: FR0005175080)

Innogenetics NV (Belgium; Euronext:INNX)

Transgene will manufacture Innogenetics' hepatitis B therapeutic vaccine candidate

The vaccine construct was developed by Transgene under a previous service agreement; terms were not disclosed (10/13)

Wave Biotech LLC*

Novavax Inc. (NVAX)

Collaboration to develop a commercial-scale production process for Novavax's avian flu vaccine and other products

They will use Wave's disposable cell culture technology in the effort; terms of the deal were not disclosed (9/13)

XOMA Ltd. (XOMA)

Cubist Pharmaceuticals Inc. (CBST)

Deal to develop new processes to manufacture the two-antibody biologic HepeX-B for Phase III trials

XOMA will develop processes for the manufacture of the two monoclonal antibodies in the hepatitis B product; longer-term and commercial deals are contemplated (9/20)

Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

OTC BB = Over-the-Counter Mulletin Board; TSE = Toronto Stock Exchange.